Robert F. Kennedy Jr.'s views on vaccines and his nomination for HHS secretary were questioned again in a second Senate hearing.
Vertex Pharmaceuticals won FDA approval for its non-opioid painkiller Journavx. Vertex stock jumped in late trading.